Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.03
GNC's Cash-to-Debt is ranked lower than
99% of the 360 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.53 vs. GNC: 0.03 )
Ranked among companies with meaningful Cash-to-Debt only.
GNC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.12 Max: N/A
Current: 0.03
Equity-to-Asset -0.03
GNC's Equity-to-Asset is ranked lower than
98% of the 361 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.42 vs. GNC: -0.03 )
Ranked among companies with meaningful Equity-to-Asset only.
GNC' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.05  Med: 0.28 Max: 0.42
Current: -0.03
-0.05
0.42
Piotroski F-Score: 4
Altman Z-Score: 1.81
Beneish M-Score: -3.56
WACC vs ROIC
3.89%
-16.15%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % -8.48
GNC's Operating Margin % is ranked lower than
94% of the 361 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.05 vs. GNC: -8.48 )
Ranked among companies with meaningful Operating Margin % only.
GNC' s Operating Margin % Range Over the Past 10 Years
Min: -8.48  Med: 13.63 Max: 17.62
Current: -8.48
-8.48
17.62
Net Margin % -12.45
GNC's Net Margin % is ranked lower than
93% of the 362 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.78 vs. GNC: -12.45 )
Ranked among companies with meaningful Net Margin % only.
GNC' s Net Margin % Range Over the Past 10 Years
Min: -12.45  Med: 6.39 Max: 10.09
Current: -12.45
-12.45
10.09
ROE % -193.49
GNC's ROE % is ranked lower than
98% of the 354 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 8.67 vs. GNC: -193.49 )
Ranked among companies with meaningful ROE % only.
GNC' s ROE % Range Over the Past 10 Years
Min: -193.49  Med: 15.97 Max: 35.82
Current: -193.49
-193.49
35.82
ROA % -13.19
GNC's ROA % is ranked lower than
94% of the 364 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.31 vs. GNC: -13.19 )
Ranked among companies with meaningful ROA % only.
GNC' s ROA % Range Over the Past 10 Years
Min: -13.19  Med: 5.45 Max: 10.02
Current: -13.19
-13.19
10.02
ROC (Joel Greenblatt) % -31.57
GNC's ROC (Joel Greenblatt) % is ranked lower than
94% of the 363 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.45 vs. GNC: -31.57 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
GNC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -31.57  Med: 48.25 Max: 72.54
Current: -31.57
-31.57
72.54
3-Year Revenue Growth Rate 10.70
GNC's 3-Year Revenue Growth Rate is ranked higher than
79% of the 318 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.10 vs. GNC: 10.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
GNC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 10.15 Max: 13.2
Current: 10.7
0
13.2
GuruFocus has detected 2 Warning Signs with GNC Holdings Inc $GNC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» GNC's 10-Y Financials

Financials (Next Earnings Date: 2017-05-16 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

GNC Guru Trades in Q1 2016

Mario Gabelli 8,300 sh (+16.90%)
Louis Moore Bacon Sold Out
Private Capital 401,972 sh (-1.44%)
Steven Cohen 545,333 sh (-29.16%)
Jim Simons 205,900 sh (-52.51%)
Joel Greenblatt 281,725 sh (-85.32%)
» More
Q2 2016

GNC Guru Trades in Q2 2016

John Burbank 1,000,000 sh (New)
Mario Gabelli 34,000 sh (+309.64%)
Joel Greenblatt 298,026 sh (+5.79%)
Jim Simons Sold Out
Steven Cohen Sold Out
Private Capital 364,759 sh (-9.26%)
» More
Q3 2016

GNC Guru Trades in Q3 2016

Paul Tudor Jones 18,790 sh (New)
Steven Cohen 294,800 sh (New)
Ray Dalio 21,261 sh (New)
Jim Simons 162,900 sh (New)
Chuck Royce 50,102 sh (New)
Mario Gabelli 44,300 sh (+30.29%)
Joel Greenblatt Sold Out
John Burbank Sold Out
Private Capital Sold Out
» More
Q4 2016

GNC Guru Trades in Q4 2016

Jim Simons 756,100 sh (+364.15%)
Chuck Royce 133,238 sh (+165.93%)
Mario Gabelli 93,300 sh (+110.61%)
Paul Tudor Jones 20,800 sh (+10.70%)
Steven Cohen Sold Out
Ray Dalio Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:GNC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers    NAICS: 446199    SIC: 5912
Compare:NAS:PETS, OTCBB:COCP, NAS:CJJD, OTCPK:OMHE, OTCPK:HEWA, OTCPK:CLCGY, OTCPK:JCOUF, NYSE:RAD, OTCPK:SDGCF, OTCPK:TSUSF, OTCPK:RADLY, NAS:WBA » details
Traded in other countries:IGN.Germany,
Headquarter Location:USA
GNC Holdings Inc is a specialty retailer of health, wellness and performance products, including vitamins, minerals and herbal supplement products (VMHS), sports nutrition products and diet products.

GNC Holdings is a specialty retailer of health and wellness products that include vitamins, herbal supplements, sports nutrition products, and diet products. The company sells a broad range of nutritional products, including proprietary and third-party brands through three segments: retail, franchise, and manufacturing/wholesale (third party). Most of GNC's revenue is derived through the retail segment, where traditional shopping mall and strip shopping center locations generate a large percentage of the segment's sales.

Top Ranked Articles about GNC Holdings Inc

9 Stocks Mario Gabelli Continues to Buy The guru's largest purchases of the 3rd and 4th quarters
Mario Gabelli (Trades, Portfolio) is the founder, chairman and CEO of Gabelli Asset Management Co. Investors (GAMCO Investors) a $30 billion global investment firm headquartered in Rye, New York. He manages a portfolio composed of 816 stocks with a total value of $15.827 billion. In the third and fourth quarters of 2016 the guru bought shares in the following stocks: Read more...
Weekly CEO Buys Highlights Insiders invest in GNC, American Assets, CNA, PJT and OPKO
According to GuruFocus’ Insider Data, these are the largest CEO buys during the past week. The overall trend of purchases is illustrated in the chart below: Read more...
Insiders Roundup: The Week's Largest Buys and Sales Netflix, American Express, Procter & Gamble top the list
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “February 2017” and All Insider Sales to “$5,000,000+.” Read more...
Stocks Mario Gabelli Has Bought for 2 Quarters The guru increased his stakes in these stocks
Mario Gabelli (Trades, Portfolio) is the founder, chairman and CEO of Gabelli Asset Management Company Investors (GAMCO Investors), a $30 billion global investment firm headquartered in Rye, New York. In both fourth quarter 2015 and first quarter 2016 the guru bought shares in the following stocks: Read more...

Ratios

vs
industry
vs
history
Forward PE Ratio 5.10
GNC's Forward PE Ratio is ranked higher than
99% of the 172 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 16.81 vs. GNC: 5.10 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PS Ratio 0.21
GNC's PS Ratio is ranked higher than
76% of the 358 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.47 vs. GNC: 0.21 )
Ranked among companies with meaningful PS Ratio only.
GNC' s PS Ratio Range Over the Past 10 Years
Min: 0.18  Med: 1.46 Max: 2.32
Current: 0.21
0.18
2.32
Price-to-Free-Cash-Flow 10.90
GNC's Price-to-Free-Cash-Flow is ranked higher than
94% of the 154 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.18 vs. GNC: 10.90 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
GNC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.75  Med: 18.32 Max: 34.38
Current: 10.9
3.75
34.38
Price-to-Operating-Cash-Flow 4.77
GNC's Price-to-Operating-Cash-Flow is ranked higher than
94% of the 198 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 10.59 vs. GNC: 4.77 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
GNC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.64  Med: 14 Max: 25.08
Current: 4.77
2.64
25.08
EV-to-EBIT -9.25
GNC's EV-to-EBIT is ranked lower than
99.99% of the 441 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.48 vs. GNC: -9.25 )
Ranked among companies with meaningful EV-to-EBIT only.
GNC' s EV-to-EBIT Range Over the Past 10 Years
Min: -14.2  Med: 12 Max: 16.5
Current: -9.25
-14.2
16.5
EV-to-EBITDA -13.01
GNC's EV-to-EBITDA is ranked lower than
99.99% of the 453 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.29 vs. GNC: -13.01 )
Ranked among companies with meaningful EV-to-EBITDA only.
GNC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -21.5  Med: 10.5 Max: 14.3
Current: -13.01
-21.5
14.3
Current Ratio 2.57
GNC's Current Ratio is ranked higher than
88% of the 345 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.21 vs. GNC: 2.57 )
Ranked among companies with meaningful Current Ratio only.
GNC' s Current Ratio Range Over the Past 10 Years
Min: 2.21  Med: 3.06 Max: 3.91
Current: 2.57
2.21
3.91
Quick Ratio 0.64
GNC's Quick Ratio is ranked lower than
53% of the 345 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.75 vs. GNC: 0.64 )
Ranked among companies with meaningful Quick Ratio only.
GNC' s Quick Ratio Range Over the Past 10 Years
Min: 0.64  Med: 1.22 Max: 1.85
Current: 0.64
0.64
1.85
Days Inventory 129.29
GNC's Days Inventory is ranked lower than
94% of the 350 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 39.37 vs. GNC: 129.29 )
Ranked among companies with meaningful Days Inventory only.
GNC' s Days Inventory Range Over the Past 10 Years
Min: 111.41  Med: 120.01 Max: 129.29
Current: 129.29
111.41
129.29
Days Sales Outstanding 17.89
GNC's Days Sales Outstanding is ranked lower than
55% of the 268 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.41 vs. GNC: 17.89 )
Ranked among companies with meaningful Days Sales Outstanding only.
GNC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.89  Med: 19.49 Max: 20.17
Current: 17.89
17.89
20.17
Days Payable 44.00
GNC's Days Payable is ranked lower than
58% of the 264 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 48.66 vs. GNC: 44.00 )
Ranked among companies with meaningful Days Payable only.
GNC' s Days Payable Range Over the Past 10 Years
Min: 28.13  Med: 31.35 Max: 44
Current: 44
28.13
44

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 7.71
GNC's Dividend Yield % is ranked higher than
99% of the 474 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.99 vs. GNC: 7.71 )
Ranked among companies with meaningful Dividend Yield % only.
GNC' s Dividend Yield % Range Over the Past 10 Years
Min: 0.27  Med: 1.44 Max: 10.47
Current: 7.71
0.27
10.47
3-Year Dividend Growth Rate 10.10
GNC's 3-Year Dividend Growth Rate is ranked higher than
59% of the 178 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.40 vs. GNC: 10.10 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
GNC' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 17.8
Current: 10.1
0
17.8
5-Year Yield-on-Cost % 7.71
GNC's 5-Year Yield-on-Cost % is ranked higher than
93% of the 505 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.97 vs. GNC: 7.71 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
GNC' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.27  Med: 1.44 Max: 10.47
Current: 7.71
0.27
10.47
3-Year Average Share Buyback Ratio 10.10
GNC's 3-Year Average Share Buyback Ratio is ranked higher than
98% of the 196 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -0.70 vs. GNC: 10.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
GNC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4.1  Med: 7 Max: 0
Current: 10.1
-4.1
0

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.23
GNC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
98% of the 207 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.48 vs. GNC: 0.23 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
GNC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.22  Med: 0.73 Max: 1.97
Current: 0.23
0.22
1.97
Price-to-Median-PS-Value 0.15
GNC's Price-to-Median-PS-Value is ranked higher than
99% of the 302 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.11 vs. GNC: 0.15 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
GNC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.14  Med: 0.99 Max: 1.49
Current: 0.15
0.14
1.49
Earnings Yield (Greenblatt) % -10.81
GNC's Earnings Yield (Greenblatt) % is ranked lower than
93% of the 488 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.09 vs. GNC: -10.81 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
GNC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -10.81  Med: 8.2 Max: 14.7
Current: -10.81
-10.81
14.7
Forward Rate of Return (Yacktman) % 41.86
GNC's Forward Rate of Return (Yacktman) % is ranked higher than
94% of the 234 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 8.25 vs. GNC: 41.86 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
GNC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 21.4  Med: 23.9 Max: 41.86
Current: 41.86
21.4
41.86

More Statistics

Revenue (TTM) (Mil) $2,516
EPS (TTM) $ -4.47
Beta0.32
Short Percentage of Float50.37%
52-Week Range $6.51 - 28.11
Shares Outstanding (Mil)68.40

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 2,439 2,408 2,584
EPS ($) 1.53 1.65 1.76
EPS without NRI ($) 1.53 1.65 1.76
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for GNC

Headlines

Articles On GuruFocus.com
GNC Holdings, Inc. First Quarter 2017 Earnings Release, Webcast and Conference Call Scheduled for Ap Apr 04 2017 
9 Stocks Mario Gabelli Continues to Buy Mar 23 2017 
Weekly CEO Buys Highlight Feb 27 2017 
GNC: Be Greedy When Others Are Fearful? Feb 10 2017 
Bob Olstein Is Pushing for Change at These Companies Dec 12 2016 
GNC is a Joel Greenblatt Bargain Walking a Tight Rope Aug 29 2016 
52-Week Company Lows Aug 03 2016 
Stocks Mario Gabelli Has Bought for 2 Quarters Jun 20 2016 
Lessons From Valeant Mar 22 2016 
Private Capital Reduces Holdings in Healthcare Stocks Dec 18 2014 

More From Other Websites
ETFs with exposure to GNC Holdings, Inc. : April 25, 2017 Apr 25 2017
GNC Holdings, Inc. :GNC-US: Earnings Analysis: Q1, 2017 By the Numbers : April 24, 2017 Apr 24 2017
What Investors Missed in the Market This Week Apr 22 2017
Is GNC a Deal or a Value Trap? Apr 21 2017
GNC Holdings, Inc. – Value Analysis (NYSE:GNC) : April 20, 2017 Apr 20 2017
GNC's New Strategy Driving Store Traffic, And Short Covering Apr 19 2017
Company News for April 19, 2017 Apr 19 2017
GNC credits Amazon marketplace, fewer promotions for improved earnings Apr 19 2017
GNC Holdings, Inc. breached its 50 day moving average in a Bullish Manner : GNC-US : April 19, 2017 Apr 19 2017
GNC Holdings (GNC) Q1 Earnings & Revenues Top, Decline Y/Y Apr 19 2017
Today's Research Reports on Stocks to Watch: GNC Holdings and Stratasys Apr 19 2017
Edited Transcript of GNC earnings conference call or presentation 18-Apr-17 12:30pm GMT Apr 18 2017
Dow Drops 113 Points as Mixed Earnings Push Stocks Lower Apr 18 2017
Why GNC Holdings, Stratasys, and Cabela's Jumped Today Apr 18 2017
Health and nutrition company GNC soars on earnings beat Apr 18 2017
GNC Stock Soars 28% Despite Mixed Q1 Earnings Apr 18 2017
Sports, cars, health care and more in the Trader Blitz Apr 18 2017
Why Shares of GNC Holdings Are Soaring Today Apr 18 2017
GNC Shorts Get Squeezed Apr 18 2017
GNC Got Thrashed in the First Quarter, but Here's Why Wall Street Sees Glimmers of Hope Apr 18 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)